ClinicalThought

Share

Program Content

Activities

  • Islatravir Dosing
    Optimizing Investigational Islatravir Dosing
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 17, 2022

  • HBV Vaccination
    HBV Vaccination in People With HIV
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 22, 2022

  • Eastern Europe
    The Impact of War in Ukraine: Studies From HIV Glasgow 2022
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 22, 2022

  • Spain: Predicting VF With LA CAB + RPV
    Predicting Virologic Failure Risk With LA CAB + RPV: Perspectives From Spain
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 21, 2022

  • LA ART Predictors
    Factors Associated With Virologic Failure With Long-Acting ART: Perspectives From Canada
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 22, 2022

  • Australia: LA ART Real-World
    Virologic Failure With Long-Acting ART in Real-World Settings: Perspectives From Australia
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 22, 2022

  • Latin America: ISL Dose Optimization and LA CAB + RPV in OPERA
    Islatravir Dose Optimization and Data on LA CAB + RPV in the Real World: Perspectives From Latin America
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 22, 2022

  • Rapid ART
    Rapid Antiretroviral Therapy Initiation: New Data and Ongoing Progress in China
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 22, 2022

  • Cryptococcal Meningitis
    Addressing the Challenge of Cryptococcal Meningitis in PWH: Perspectives From Sub-Saharan Africa
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2022

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare